HLA-C and neoplasm: Bispecific antibodies are recombinant antibodies with two fragment antigen binding (Fab) regions, one targeting a receptor on T-cells, the other targeting an MHC-restricted antigen on tumor cells, thus enabling the recruitment of T-cells to kill tumor cells.